Abigail
Diagnosed with a grade 3 invasive ductal carcinoma in Zimbabwe, Abigail travelled to India for surgery, radiation and hormone therapy. Five years on, she is well with no evidence of disease.
Why the Family Contacted CancerFax
Abigail's family were not doctors. They were trying to understand an aggressive diagnosis, work out what tests were still missing, and find a hospital that could deliver the whole plan, all while coping with the shock of the news. They needed someone to organise the path for them.
Abigail needed staging, surgery, radiation and drug therapy under one roof, not scattered across different centres. Identifying a hospital with that complete capability needed specialist knowledge.
Hormone receptor status, HER2 and full staging all had to be confirmed before the right treatment could begin. Knowing what to ask for required clinical literacy.
Medical records, cost estimates, visa support, travel and hospital communication all had to be coordinated across two countries.
"We had the biopsy result in our hands but no idea what to do next. CancerFax helped us understand the diagnosis and showed us a clear path forward."— Abigail's family
How CancerFax Helped
CancerFax reviewed Abigail's biopsy report, helped the family understand what it meant, and identified a comprehensive cancer centre in India that could carry out staging, surgery, radiation and hormone therapy as a single coordinated plan. We then helped organise the evaluation, the cost estimate and the practical side of travelling for treatment.
Abigail's histopathology report and clinical history were compiled and structured so the oncology team in India could review the case quickly and accurately.
CancerFax identified HCG EKO Cancer Centre in Kolkata, a dedicated cancer hospital able to provide surgical, radiation and medical oncology together with PET-CT and diagnostics under one roof.
A clear evaluation plan and a transparent cost estimate were prepared in advance, so the family knew what to expect before committing to travel.
Guidance on the medical visa invitation, documents and logistics was provided so Abigail and her attendant could travel for treatment with less stress.
Abigail's Treatment Journey
Key steps from diagnosis in Zimbabwe to recovery in India and beyond.
In early 2019, Abigail noticed a small, very hard lump in her right breast. With no family history of cancer, she went for assessment in Bulawayo.
A biopsy in Zimbabwe confirmed a grade 3 invasive ductal carcinoma with high-grade ductal carcinoma in situ and angiolymphatic invasion. The excision was incomplete, so further treatment was clearly needed.
With the diagnosis confirmed but the plan unclear, the family contacted CancerFax. We reviewed the report and identified HCG EKO Cancer Centre in Kolkata as a centre able to deliver the complete plan.
Abigail travelled to India, where the team carried out PET-CT staging and confirmed hormone receptor, HER2 and Ki67 status to finalise her individual treatment plan.
She underwent definitive breast surgery, followed by radiation therapy to reduce the risk of the cancer returning.
Because her cancer was hormone receptor positive, Abigail continued on hormone therapy, with regular follow-up to monitor her recovery.
Today, five years after her treatment, Abigail is living a normal, active life with no evidence of disease.
Every patient's treatment plan is individual. The pathway above describes this specific case — not a blueprint for others. Suitability for each treatment is determined by the treating clinical team based on each patient's individual clinical situation.
Where Abigail Is Today
Five years after completing surgery and radiation in India, Abigail is well. Her follow-up assessments have shown no evidence of disease, and she continues with hormone therapy and routine monitoring as planned by her oncology team.
She has returned to her normal daily life in Zimbabwe. For a diagnosis that began with an aggressive, grade 3 tumour, reaching five years with no evidence of disease is a meaningful and reassuring milestone.
“"I feel completely myself again. Five years ago I was frightened and did not know where to turn. Today I am living my life normally, and I am grateful for the people who guided me."”— Abigail, Patient
What Other Families Can Learn
Abigail's journey shows what is possible when an aggressive diagnosis is met with a complete, well organised plan rather than piecemeal steps.
A cancer diagnosis usually needs further staging and testing before the right treatment can begin. Knowing what is still missing is half the battle.
These tests decide whether hormone therapy or targeted drugs are suitable, so confirming them early shapes the whole plan.
Higher grade tumours with vascular invasion benefit from prompt, complete treatment. Moving without long gaps can make a real difference.
When local options are scattered or limited, a single comprehensive centre with navigation support can deliver staging, surgery, radiation and drug therapy in one place.
Related on CancerFax
Frequently Asked Questions
This patient story reflects an individual treatment journey. Outcomes vary from patient to patient. The information on this page should not be taken as medical advice or a guarantee of similar results. Treatment suitability depends on diagnosis, disease status, prior therapy, molecular findings, overall health, and specialist medical evaluation. Names and identifying details may be modified to protect patient privacy. All clinical decisions must be made in consultation with a qualified, licensed physician with access to the patient's complete medical information.
Need Help Understanding the Next Step?
If you or a loved one is facing a complex cancer diagnosis, relapse, or limited treatment options, CancerFax can help you organise the case, explore relevant hospitals and doctors, and understand whether advanced treatment or clinical trial pathways may be appropriate.
© CancerFax · Patient navigation and coordination platform. CancerFax is not a medical institution and does not provide medical treatment. All clinical care is provided by independent licensed physicians and hospitals. Patient names and identifying details are modified or anonymised where required to protect privacy. Story shared with documented family consent.